Hypercalcaemia after Oclacitinib (Apoquel) in dogs

99 reports to the FDA describe hypercalcaemia in dogs given Oclacitinib. That is 0.3% of all reports for this medicine, compared with 0.2% across reports for all dog medicines, so it is reported unusually often with this medicine.

99Reports
49%Marked serious
5.1%Recovered
12%Died or euthanised
77 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
5 8.2%
1–2 days
4 6.6%
3–7 days
2 3.3%
1–4 weeks
14 23%
Over a month
36 59%

How the animals did

Recovered
5 5.1%
Still unwell when reported
74 75%
Died
4 4.0%
Euthanised
8 8.1%
Not known
8 8.1%

Problems reported at the same time

Age of the animals

Under 1 year
0
1–3 years
10
4–7 years
27
8–11 years
40
12+ years
20

About this medicine

Oclacitinib controls itching from allergies (tablet, a JAK inhibitor).

Products with this ingredient include Apoquel. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Oclacitinib cause hypercalcaemia in dogs?
99 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 77 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hypercalcaemia with similar medicines

All reported side effects of Oclacitinib in dogs · Medicines most reported with hypercalcaemia